Press Releases Orthocell Limited

Equities

Delayed Australian S.E. Other stock markets 01:31:12 14/05/2024 BST			5-day change	1st Jan Change
0.4 ^AUD	+2.56%		+6.67%	-2.44%

04-15	Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	MT
04-09	Orthocell Revenue Soars 19% to AU$1.61 Million in Q1	MT

Orthocell raising $3.5 million; adds heavy hitters to register	02-23	AQ
Orthocell on the cusp of significant growth	11-01	AQ
Orthocell thrilled to welcome John Van Der Wielen as chairman	29/05/23	AQ
Orthocell welcomes globally recognised nerve surgeons to advisory board	30/03/23	AQ
Orthocell welcomes high profile US-based healthcare specialist to the board	08/03/23	AQ
Orthocell : Notification regarding unquoted securities - OCC	21/04/22	PU
Orthocell : Application for quotation of securities - OCC	30/12/21	PU
Orthocell : Application for quotation of securities - OCC	23/12/21	PU
Orthocell : Application for quotation of securities - OCC	16/12/21	PU
Orthocell : OrthoATI Tendon Clinical Study Success	07/12/21	PU
Orthocell : Application for quotation of securities - OCC	18/11/21	PU
Application for quotation of securities - OCC	09/11/21	PU
Orthocell : Receives US Market Clearance	15/01/21	BU
Orthocell : Positive Pre-Clinical Results Using CelGro® in Anterior Cruciate Ligament (ACL) Reconstruction	05/02/18	BU
Orthocell : Secures New Patent for Suture-Less Repair of Soft Tissue	18/01/18	BU
Orthocell : Granted European Tendon Regeneration Patent	15/12/17	BU
Orthocell : Commences Treatment of Its 1,000th Patient	07/12/17	BU
Orthocell : Receives CE Mark for CelGro®	09/11/17	BU
Orthocell : Appoints Surgical Specialties as Exclusive Distributor	11/10/17	BU
Orthocell : 1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study	05/09/17	BU

No results for this search